Alfacalcidol: Difference between revisions
Content deleted Content added
illustration is added |
Fixed the effect of calcitriol and alfacalcidiol on PTH, which was inverted. Also fixed link to study. |
||
Line 49: | Line 49: | ||
'''Alfacalcidol''' (or '''1-hydroxycholecalciferol''') is an analogue of [[vitamin D]] used for supplementation in humans and as a poultry feed additive. |
'''Alfacalcidol''' (or '''1-hydroxycholecalciferol''') is an analogue of [[vitamin D]] used for supplementation in humans and as a poultry feed additive. |
||
Alfacalcidol has a weaker impact on [[calcium metabolism]] than [[calcitriol]],<ref>Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781231/]</ref> |
Alfacalcidol has a weaker impact on [[calcium metabolism]] than [[calcitriol]],<ref>Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781231/]</ref> and on [[parathyroid hormone]] levels<ref>Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [http://www.jptcp.com/cjcp07017_wazny_e36-e43v2-r101690]</ref>, however alfacalcidiol has significant effects on the [[immune system]], including [[regulatory T cells]].<ref>Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;</ref> It is considered{{by whom|date=September 2012}} to be a more useful form of [[vitamin D]] supplementation, mostly due to much longer half-life and lower kidney load.<ref>Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [http://www.ncbi.nlm.nih.gov/pubmed/16283320]</ref> |
||
Used as a poultry feed additive, it prevents [[tibial dyschondroplasia]] and increases [[phytate]] bioavailability.<ref>[http://www.vitaminderivatives.com VDI Product Data]</ref>{{or|date=October 2010}} |
Used as a poultry feed additive, it prevents [[tibial dyschondroplasia]] and increases [[phytate]] bioavailability.<ref>[http://www.vitaminderivatives.com VDI Product Data]</ref>{{or|date=October 2010}} |
Revision as of 08:25, 4 December 2013
Names | |
---|---|
IUPAC name
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-Methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
| |
Other names
Alphacalcidol; 1-Hydroxycholecalciferol
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.050.253 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C27H44O2 | |
Molar mass | 400.64 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Alfacalcidol (or 1-hydroxycholecalciferol) is an analogue of vitamin D used for supplementation in humans and as a poultry feed additive.
Alfacalcidol has a weaker impact on calcium metabolism than calcitriol,[1] and on parathyroid hormone levels[2], however alfacalcidiol has significant effects on the immune system, including regulatory T cells.[3] It is considered[by whom?] to be a more useful form of vitamin D supplementation, mostly due to much longer half-life and lower kidney load.[4]
Used as a poultry feed additive, it prevents tibial dyschondroplasia and increases phytate bioavailability.[5][original research?]
References
- ^ Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [1]
- ^ Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [2]
- ^ Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;
- ^ Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [3]
- ^ VDI Product Data